Ozren Jaksic

15PUBLICATIONS
200CO-AUTHORS
BiomechanicsPredictive and prognostic markersHaematological tumoursHaematologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 28, 2024
Athlete biological passport: longitudinal biomarkers and statistics in the fight against doping.

Dora Dragčević, Vlatka Pandžić Jakšić, Ozren Jakšić

|Feb 24, 2024
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases.

Igor Aurer, Ozren Jakšić, Sandra Bašić-Kinda

|Sep 29, 2023
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò

|Mar 21, 2023
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem).

Zdravko Mitrovic, Dino Dujmovic, Ozren Jaksic

|Sep 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.

Livio Pagano, Jon Salmanton-García, Francesco Marchesi

|Oct 15, 2021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

Livio Pagano, Jon Salmanton-García, Francesco Marchesi

Pageof 3

Frequent Collaborators

6 joint publications

Livio Pagano

6 joint publications

Jon Salmanton-García

6 joint publications

Martin Hoenigl

6 joint publications

Francesco Marchesi